LAGB as a Treatment for Morbid Obesity in Adolescents

NACompletedINTERVENTIONAL
Enrollment

137

Participants

Timeline

Start Date

September 13, 2005

Primary Completion Date

July 31, 2016

Study Completion Date

April 30, 2017

Conditions
Morbid ObesityObstructive Sleep Apnea SyndromeMetabolic SyndromeInsulin ResistanceNonalcoholic Fatty Liver Disease
Interventions
DEVICE

Laparoscopic adjustable gastric banding (Allergan Lap Band)

Pre-op evaluation, surgical placement of a gastric band, and follow-up for a minimum of 5 years after surgery. Surgery is laparoscopic adjustable gastric band placement using a single brand of gastric band. Evaluations before and after surgery include but are not limited to history and physical examination, serum chemistry studies, imaging, sleep studies, and pulmonary function testing.

Trial Locations (1)

10032

Morgan Stanley Children's Hospital of NY Presbyterian, New York

All Listed Sponsors
lead

Jeffrey L Zitsman, MD

OTHER

NCT01045499 - LAGB as a Treatment for Morbid Obesity in Adolescents | Biotech Hunter | Biotech Hunter